血浆激肽释放酶从牛高分子量激肽原释放的新肽片段的可能生理作用。 - Suppr | 超能文献

Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein.

作者信息

Oh-ishi S, Katori M, Nam Han Y, Iwanaga S, Kato H

出版信息

Biochem Pharmacol. 1977 Jan 15;26(2):115-20. doi: 10.1016/0006-2952(77)90381-1.

DOI:10.1016/0006-2952(77)90381-1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein.血浆激肽释放酶从牛高分子量激肽原释放的新肽片段的可能生理作用。

Biochem Pharmacol. 1977 Jan 15;26(2):115-20. doi: 10.1016/0006-2952(77)90381-1.

2

Surface activation of blood coagulation, fibrinolysis and kinin formation.血液凝固、纤维蛋白溶解和激肽形成的表面激活。

Nature. 1980 Jul 31;286(5772):456-60. doi: 10.1038/286456a0.

3

Release of a new vascular permeability enhancing peptide from kininogens by human neutrophil elastase.

Biochem Biophys Res Commun. 2002 Jun 7;294(2):423-8. doi: 10.1016/S0006-291X(02)00490-4.

4

Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.弗洛热亚克因子缺乏症。用高度纯化的牛高分子量激肽原进行重建，并鉴定血浆激肽释放酶从牛高分子量激肽原释放的一种新的通透性增强肽。

J Clin Invest. 1976 Dec;58(6):1395-406. doi: 10.1172/JCI108595.

5

Primary structure of bovine plasma high-molecular-weight kininogen. Characterization of carbohydrate-free fragment 1.2 (fragment X) released by the action of plasma kallikrein and its biological activity.牛血浆高分子量激肽原的一级结构。血浆激肽释放酶作用释放的无糖基化片段1.2（片段X）的表征及其生物活性。

J Biochem. 1978 Jan;83(1):213-21. doi: 10.1093/oxfordjournals.jbchem.a131894.

6

The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.接触因子依赖的凝血、纤维蛋白溶解和激肽生成途径。

Semin Thromb Hemost. 1976 Jul;3(1):1-26. doi: 10.1055/s-0028-1087162.

7

The kinins. A status report.激肽。一份现状报告。

Biochem Pharmacol. 1976 Jul 15;25(14):1563-9. doi: 10.1016/0006-2952(76)90465-2.

8

High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.

Thromb Res. 1979;14(6):817-24. doi: 10.1016/0049-3848(79)90001-x.

9

Formation and function of kinins.激肽的形成与功能。

Rheumatology. 1970;3(0):103-68.

10

Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein.凝血酶、纤溶酶和激肽释放酶形成过程中的表面介导反应。

Br Med Bull. 1978 May;34(2):107-12. doi: 10.1093/oxfordjournals.bmb.a071479.

引用本文的文献

1

Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation.慢性硬膜下血肿中的激肽释放酶-激肽系统：其在血管通透性以及纤维蛋白溶解和凝血调节中的作用

J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):388-94. doi: 10.1136/jnnp.59.4.388.

2

Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.人、牛和兔血浆中的前激肽释放酶激活：牛血浆中存在一种抑制剂。

Inflammation. 1992 Jun;16(3):205-13. doi: 10.1007/BF00918810.

3

Inhibition of prekallikrein activation in human plasma by components of bovine plasma.牛血浆成分对人血浆中前激肽释放酶激活的抑制作用。

Inflammation. 1992 Oct;16(5):497-507. doi: 10.1007/BF00918975.